Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57... (IQUE(R) contraceptive products. We expan...)

Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share

Date:5/8/2008

IQUE(R) contraceptive products. We expanded the proprietary product portfolio with the launch of the AmniScreen(TM) product, the first and only FDA-approved, prescription, at-home screening test for amniotic fluid leakage during pregnancy. We also launched SEASONALE(R) in Canada with our marketing partner, Paladin."

Revenues

Generic Product Sales

The Company's generic product sales were $469 million for the quarter ended March 31, 2008, compared to $471 million in the prior year period.

U.S. Generic Sales

Sales of U.S. generic products totaled $261 million for the first quarter

of 2008, compared to $307 million in the prior year period. The $46

million decrease in sales is primarily related to lower sales of several

of the Company's products including Ondansetron ODT, Cyclosporine Capsules

and Desmopressin. These decreases were partially offset by increases in

sales of Fentanyl Citrate and the launch of the Company's Alendronate

product.

Sales of generic oral contraceptives, the Company's largest single

category of generic products, were lower in the quarter, as expected,

decreasing to $93 million in the first quarter of 2008 from $113 million

in the prior year period. The decrease primarily reflects lower volume on

several products due to lower market share.

Europe and Rest of the World ("ROW") Generic Sales

Sales of European and ROW generic products were $208 million in the first

quarter of 2008, compared to $164 million in the prior year period. This

$44 million increase is primarily related to the positive impact of

foreign currency exchange during the quarter and higher sales in the

Company's key markets of Germany, Russia and Poland.

Proprietary Product Sales

The Company's proprietary product sales were $96 million for the first quarter of 2008, up from $89 million in the prior year period. The increase
'/>"/>

0

GOOD

Post Your Comments:

Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57...(IQUE(R) contraceptive products. We expan...)